Acute administration of chloral hydrate depletes cardiac enzymes in the rat

Acta Anatomica
|January 1, 1987
PubMed

Insights

Chloral hydrate administration in rats altered key enzymes involved in energy metabolism within the left ventricle arterioles. Even at nontoxic doses, this drug may impair coronary metabolism.

Area of Science:

  • Biochemistry
  • Cardiovascular Physiology
  • Pharmacology

Background:

  • Coronary metabolism is crucial for cardiac function.
  • Understanding the impact of anesthetics on cardiac metabolism is important for patient safety.

Purpose of the Study:

  • To investigate the effects of chloral hydrate on enzymes of aerobic and anaerobic metabolism in rat cardiac arterioles.
  • To assess the impact on the hexosemonophosphate shunt pathway.

Main Methods:

  • Histochemical analysis of left cardiac ventricle arterioles in rats.
  • Examination of five key metabolic enzymes.
  • Acute administration of chloral hydrate.

Main Results:

  • Significant alterations were observed in three out of five enzymes studied.
  • Changes indicated potential disruption in both aerobic and anaerobic metabolic pathways.
  • The hexosemonophosphate shunt pathway may also be affected.

Conclusions:

  • Nontoxic levels of chloral hydrate can induce changes in coronary metabolism.
  • Further research is needed to elucidate the precise mechanisms and clinical implications.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...